Clock-like Mutation Signature May Be Prognostic for Worse Survival Than Signatures of UV Damage in Cutaneous Melanoma

SIMPLE SUMMARY: Although immunotherapy and targeted therapy have dramatically improved melanoma survival, some patients rapidly progress and decease within a few months after a stage IV diagnosis. Up until now, pathological, clinical and biological markers are known prognostic factors for survival o...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Fabienne, Ramelyte, Egle, Turko, Patrick, Dzung, Andreas, Freiberger, Sandra N., Mangana, Joanna, Levesque, Mitchell P., Dummer, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418148/
https://www.ncbi.nlm.nih.gov/pubmed/37568633
http://dx.doi.org/10.3390/cancers15153818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418148/
https://www.ncbi.nlm.nih.gov/pubmed/37568633
http://dx.doi.org/10.3390/cancers15153818

Ejemplares similares